Literature DB >> 10531213

Repeated administration of synthetic oligodeoxynucleotides expressing CpG motifs provides long-term protection against bacterial infection.

D M Klinman1, J Conover, C Coban.   

Abstract

Synthetic oligodeoxynucleotides (ODN) expressing unmethylated CpG motifs stimulate an innate immune response characterized by the production of polyreactive immunoglobulin M antibodies and immunomodulatory cytokines. This immune response has been shown to protect mice from challenge by Listeria monocytogenes and Francisella tularensis for up to 2 weeks. By repeatedly administering CpG ODN two to four times/month, we found that this protection could be maintained indefinitely. Protection was associated with a significant increase in the number of spleen cells that could be triggered by subsequent pathogen exposure to secrete gamma interferon and interleukin-6 in vivo (P < 0.01). ODN-treated animals remained healthy and developed neither macroscopic nor microscopic evidence of tissue damage or inflammation. Thus, repeated administration of CpG ODN may provide a safe means of conferring long-term protection against infectious pathogens.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10531213      PMCID: PMC96939     

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  28 in total

1.  CpG motifs as immune adjuvants.

Authors:  D M Klinman; K M Barnhart; J Conover
Journal:  Vaccine       Date:  1999-01       Impact factor: 3.641

2.  Proliferation of anti-DNA-producing NZB B cells in a non-autoimmune environment.

Authors:  D M Klinman; A D Steinberg
Journal:  J Immunol       Date:  1986-07-01       Impact factor: 5.422

Review 3.  Subversion of the immune system by pathogens.

Authors:  P Marrack; J Kappler
Journal:  Cell       Date:  1994-01-28       Impact factor: 41.582

4.  CpG motifs present in bacteria DNA rapidly induce lymphocytes to secrete interleukin 6, interleukin 12, and interferon gamma.

Authors:  D M Klinman; A K Yi; S L Beaucage; J Conover; A M Krieg
Journal:  Proc Natl Acad Sci U S A       Date:  1996-04-02       Impact factor: 11.205

Review 5.  DNA methylation and its possible biological roles.

Authors:  A Razin; J Friedman
Journal:  Prog Nucleic Acid Res Mol Biol       Date:  1981

6.  CpG motifs in bacterial DNA trigger direct B-cell activation.

Authors:  A M Krieg; A K Yi; S Matson; T J Waldschmidt; G A Bishop; R Teasdale; G A Koretzky; D M Klinman
Journal:  Nature       Date:  1995-04-06       Impact factor: 49.962

7.  Bacterial DNA induces NK cells to produce IFN-gamma in vivo and increases the toxicity of lipopolysaccharides.

Authors:  J S Cowdery; J H Chace; A K Yi; A M Krieg
Journal:  J Immunol       Date:  1996-06-15       Impact factor: 5.422

8.  Unique palindromic sequences in synthetic oligonucleotides are required to induce IFN [correction of INF] and augment IFN-mediated [correction of INF] natural killer activity.

Authors:  S Yamamoto; T Yamamoto; T Kataoka; E Kuramoto; O Yano; T Tokunaga
Journal:  J Immunol       Date:  1992-06-15       Impact factor: 5.422

9.  Bacterial DNA induces murine interferon-gamma production by stimulation of interleukin-12 and tumor necrosis factor-alpha.

Authors:  M D Halpern; R J Kurlander; D S Pisetsky
Journal:  Cell Immunol       Date:  1996-01-10       Impact factor: 4.868

10.  Induction of anti-double stranded DNA antibodies in normal mice by immunization with bacterial DNA.

Authors:  G S Gilkeson; J P Grudier; D G Karounos; D S Pisetsky
Journal:  J Immunol       Date:  1989-03-01       Impact factor: 5.422

View more
  41 in total

1.  Contribution of nitric oxide to CpG-mediated protection against Listeria monocytogenes.

Authors:  Shuichi Ito; Ken J Ishii; Atsushi Ihata; Dennis M Klinman
Journal:  Infect Immun       Date:  2005-06       Impact factor: 3.441

2.  CpG-oligodeoxynucleotide is a potent adjuvant with an Entamoeba histolytica Gal-inhibitable lectin vaccine against amoebic liver abscess in gerbils.

Authors:  Catherine P A Ivory; Kathy Keller; Kris Chadee
Journal:  Infect Immun       Date:  2006-01       Impact factor: 3.441

3.  CpG oligodeoxyribonucleotides protect mice from Burkholderia pseudomallei but not Francisella tularensis Schu S4 aerosols.

Authors:  David A Rozak; Herbert C Gelhaus; Mark Smith; Mojgan Zadeh; Louis Huzella; David Waag; Jeffrey J Adamovicz
Journal:  J Immune Based Ther Vaccines       Date:  2010-02-05

4.  Effect of CpG oligodeoxynucleotides on the immunogenicity of Pfs25, a Plasmodium falciparum transmission-blocking vaccine antigen.

Authors:  Cevayir Coban; Ken J Ishii; Anthony W Stowers; David B Keister; Dennis M Klinman; Nirbhay Kumar
Journal:  Infect Immun       Date:  2004-01       Impact factor: 3.441

5.  Innate immune responses induced by CpG oligodeoxyribonucleotide stimulation of ovine blood mononuclear cells.

Authors:  Angelo Mena; Anil K Nichani; Yurij Popowych; Dale L Godson; Donna Dent; Hugh G G Townsend; George K Mutwiri; Rolf Hecker; Lorne A Babiuk; Philip Griebel
Journal:  Immunology       Date:  2003-10       Impact factor: 7.397

6.  Toll-like receptor 9-dependent macrophage activation by Entamoeba histolytica DNA.

Authors:  Catherine P A Ivory; Michael Prystajecky; Christian Jobin; Kris Chadee
Journal:  Infect Immun       Date:  2007-11-05       Impact factor: 3.441

7.  Proteomic evidence of bacterial peptide translocation in afebrile patients with cirrhosis and ascites.

Authors:  Rocío Caño; Lucía Llanos; Pedro Zapater; Sonia Pascual; Pablo Bellot; Claudia Barquero; Miguel Pérez-Mateo; José Such; Rubén Francés
Journal:  J Mol Med (Berl)       Date:  2010-01-20       Impact factor: 4.599

8.  Immunostimulatory CpG oligodeoxynucleotide confers protection in a murine model of infection with Burkholderia pseudomallei.

Authors:  Surasakdi Wongratanacheewin; Wannapa Kespichayawattana; Pakamas Intachote; Sathit Pichyangkul; Rasana W Sermswan; Arthur M Krieg; Stitaya Sirisinha
Journal:  Infect Immun       Date:  2004-08       Impact factor: 3.441

9.  Protection against experimental melioidosis following immunization with live Burkholderia thailandensis expressing a manno-heptose capsule.

Authors:  Andrew E Scott; Thomas R Laws; Riccardo V D'Elia; Margaret G M Stokes; Tannistha Nandi; E Diane Williamson; Patrick Tan; Joann L Prior; Timothy P Atkins
Journal:  Clin Vaccine Immunol       Date:  2013-05-15

10.  CpG oligodeoxynucleotides stimulate protective innate immunity against pulmonary Klebsiella infection.

Authors:  Jane C Deng; Thomas A Moore; Michael W Newstead; Xianying Zeng; Arthur M Krieg; Theodore J Standiford
Journal:  J Immunol       Date:  2004-10-15       Impact factor: 5.422

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.